New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read MorePosted by Andy Lundin | Jul 29, 2024 | Lung Cancer |
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read MorePosted by Andy Lundin | Jul 25, 2024 | Unknown Origin & Other Cancer Types |
A blood test measuring lymphocyte levels may predict the effectiveness of CAR-T immunotherapy in relapsed multiple myeloma patients.
Read MorePosted by Chris Wolski | Jul 1, 2024 | Mass Spectrometry Instruments |
Researchers conducted a comprehensive study on multiple myeloma, identifying early detection methods for aggressive tumors.
Read MorePosted by Chris Wolski | Jun 25, 2024 | Hematology & Serology |
The CLP May/June 2024 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers.
Read MorePosted by Andy Lundin | Jun 24, 2024 | Hematology Instrumentation |
Horiba expanded its line of hematology instruments by introducing new models that integrate Erythrocyte Sedimentation Rate (ESR) testing.
Read More